Tag Archives: Prof Olav Mella

Genetic research: Fine mapping of the major histocompatibility complex (MHC) in ME/CFS

Fine mapping of the major histocompatibility complex (MHC) in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) suggests involvement of both HLA class I and class II loci, by Riad Hajdarevic, Asgeir Lande, Ingrid Rekeland, Anne Rydland, Elin B Strand, Daisy D Sosa, … Continue reading

Posted in News | Tagged , , , , , , , , , , , , , , , | Comments Off on Genetic research: Fine mapping of the major histocompatibility complex (MHC) in ME/CFS

Research: A map of metabolic phenotypes in patients with ME/CFS

A map of metabolic phenotypes in patients with myalgic encephalomyelitis/ chronic fatigue syndrome by Fredrik Hoel, August Hoel, Ina Kn Pettersen, Ingrid G Rekeland, Kristin Risa, Kine Alme, Kari Sørland, Alexander Fosså, Katarina Lien, Ingrid Herder, Hanne L Thürmer, Merete … Continue reading

Posted in News | Tagged , , , , , , , , , , , , , , , , , , , , , , | Comments Off on Research: A map of metabolic phenotypes in patients with ME/CFS

Research: Pathomechanisms & possible interventions in ME/CFS

Pathomechanisms and possible interventions in myalgic encephalomyelitis/ chronic fatigue syndrome (ME/CFS), by Øystein Fluge, Karl J. Tronstad, and Olav Mella in J Clin Invest. 2021;131(14):e150377 [doi.org/10.1172/JCI150377] July 15, 2021   Research abstract: Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a disease with … Continue reading

Posted in News | Tagged , , , , , | Comments Off on Research: Pathomechanisms & possible interventions in ME/CFS

Intravenous cyclophosphamide in ME/CFS. An open-label phase II study

Intravenous Cyclophosphamide in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. An Open-Label Phase II Study by Ingrid G Rekeland, Alexander Fosså, Asgeir Lande, Irini Ktoridou-Valen, Kari Sørland, Mari Holsen, Karl J Tronstad, Kristin Risa, Kine Alme, Marte K Viken, Benedicte A Lie, Olav … Continue reading

Posted in News | Tagged , , , , , , , , , , , , , , , , , | Comments Off on Intravenous cyclophosphamide in ME/CFS. An open-label phase II study

Human Leukocyte Antigen alleles associated with ME/CFS

Human Leukocyte Antigen alleles associated with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS), by Asgeir Lande, Øystein Fluge, Elin B Strand, Siri T Flåm, Daysi D Sosa, Olav Mella, Torstein Egeland, Ola D Saugsta, Benedicte A Lie, Marte K Viken in Scientific … Continue reading

Posted in News | Tagged , , , , , , , , , , , , , | Comments Off on Human Leukocyte Antigen alleles associated with ME/CFS

B-Lymphocyte depletion in patients with ME/CFS: the final rituximab trial results

B-lymphocyte depletion in patients With Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome: a randomized, double-blind, placebo-controlled trial by Oystein Fluge, Ingrid G. Rekeland, Katarina Lien, Hanne Thurmer, Petter C. Borchgrevink, Christoph Schafer, Kari Sorland, Jorg Assmus, Irini Ktoridou-Valen, Ingrid Herder, Merethe E. … Continue reading

Posted in News | Tagged , , , , , | Comments Off on B-Lymphocyte depletion in patients with ME/CFS: the final rituximab trial results

Immunosignature analysis of ME/CFS – promising diagnostic biomarker

Immunosignature Analysis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Oliver P Günther, Jennifer L Gardy, Phillip Stafford, Øystein Fluge, Olav Mella, Patrick Tang, Ruth R Miller, Shoshana M Parker, Stephen A Johnston, David M Patrick in Molecular Neurobiology (2018) pp 1-9 [Published online: … Continue reading

Posted in News | Tagged , , , , , , , , , , , , , | Comments Off on Immunosignature analysis of ME/CFS – promising diagnostic biomarker

Norwegian rituximab trial reports negative results

The Norwegian Rituximab trial reports negative results ahead of the publication of the full results. Attempts are now under way to determine the best way forward in understanding what has been learned and how to find out which patients may still benefit from … Continue reading

Posted in News | Tagged , , , , , , | Comments Off on Norwegian rituximab trial reports negative results

Norwegian Rituximab studies update

Helse Bergen blog post, 29 Sep 29017: RituxME B-lymphocyte depletion using the anti-CD20 antibody rituximab (Mabthera®) in Myalgic Encephalopathy/Chronic Fatigue Syndrome (“RituxME”) ​RituxME is a multicentre study conducted in five study centres in Norway: the Oncology Department at Haukeland University … Continue reading

Posted in News | Tagged , , , , , | Comments Off on Norwegian Rituximab studies update

Fuel shortage: Norwegian study expands on energy problem in ME/CFS

Health rising blog post, by Cort Johnson, 27 Dec 2016: Fuel shortage: Norwegian study Expands on Energy Problem in Chronic Fatigue Syndrome (ME/CFS) Fluge and Mella seem to be working at almost lightning speed. Besides managing their huge Rituximab study … Continue reading

Posted in News | Tagged , , , , , , | Comments Off on Fuel shortage: Norwegian study expands on energy problem in ME/CFS